ABCG1 and breast cancer: The clinical response to NAC in BC patients showing ABCC1 (16p13.1), ABCC 2 (10q24),ABCG1 (21q22.3) and ABCG2 (4q22.1) gene loci deletions varied little, ranging from 62% to 88%.